PURE BIOSCIENCE, INC. Quarterly Deferred Tax Assets, Gross in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Pure Bioscience, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q2 2011 to Q2 2024.
  • Pure Bioscience, Inc. Deferred Tax Assets, Gross for the quarter ending July 31, 2024 was $29.3M, a 3.33% decline year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $29.3M -$1.01M -3.33% Jul 31, 2024 10-K 2024-10-29
Q2 2023 $30.3M +$820K +2.78% Jul 31, 2023 10-K 2024-10-29
Q2 2022 $29.5M +$670K +2.32% Jul 31, 2022 10-K 2023-10-30
Q2 2021 $28.8M +$470K +1.66% Jul 31, 2021 10-K 2022-10-28
Q2 2020 $28.4M -$470K -1.63% Jul 31, 2020 10-K 2021-10-28
Q2 2019 $28.8M +$210K +0.73% Jul 31, 2019 10-K 2020-10-08
Q2 2018 $28.6M -$5.45M -16% Jul 31, 2018 10-K 2019-10-30
Q2 2017 $34.1M +$810K +2.44% Jul 31, 2017 10-K 2018-10-25
Q2 2016 $33.3M +$2.43M +7.86% Jul 31, 2016 10-K 2017-10-26
Q2 2015 $30.8M +$3.08M +11.1% Jul 31, 2015 10-K 2016-10-27
Q2 2014 $27.8M +$3.12M +12.7% Jul 31, 2014 10-K 2015-10-28
Q2 2013 $24.6M +$2.09M +9.26% Jul 31, 2013 10-K 2014-10-28
Q2 2012 $22.6M +$2.66M +13.4% Jul 31, 2012 10-K 2013-10-24
Q2 2011 $19.9M Jul 31, 2011 10-K 2012-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.